MICHIE BOLDEN: Open Payments
NPI 1659815736 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 6 companies in 2025. Trend: 2023 $378 · 2024 $548 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| Alkermes, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $31 |
| Corium, LLC | 1 | $25 |
| Neuronetics, Inc. | 1 | $12 |
Products named: CAPLYTA, Qelbree, VRAYLAR, Azstarys, ARISTADA, LYBALVI, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across VA — which companies pay providers there.
